Answer
Breastfeeding should be discontinued throughout tepotinib treatment and for at least 1 week after the last dose.
Sources for this answer
- Tepotinib 225 mg film-coated tabletsMerck · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked